Overview

Single Use Bioreactors Market is poised to value over CAGR of over 21% during the forecast period 2022 to 2028

FutureWise Market Research has instantiated a report that provides an intricate analysis of Single Use Bioreactors Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Single Use Bioreactors Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business Molecule Type.

Major players included in the Single Use Bioreactors Market:
• Sartorius Stedim Biotech
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck Millipore
• Eppendorf Ag
• Cesco Bioengineering Co., Ltd.
• Cellexus
• PBS Biotech, Inc.
• Distek, Inc.
• Abec, Inc.
• Able Corporation & Biott Corporation
• G&G Technologies, Inc.
• Solida Biotech Gmbh
• Satake Chemical Equipment Mfg., Ltd.
• Stobbe Pharma Gmbh
• Celltainer Biotech BV
• Meissner Filtration Products, Inc.
• BBI-Biotech Gmbh
• Pierre Guérin
(Note: The list of the major players will be updated with the latest market scenario and trends)

Single Use Bioreactors Market Segmentation:
By Product
• Single-use Bioreactor Systems
 o Up to 10L
 o 11–100L
 o 101–500L
 o 501–1500L
 o Other Cells (Insect and plant cells)
• Single-use Media Bags
 o 2D Bags
 o 3D Bags
 o Other Bags
• Single-use Filtration Assemblies
• Other Products (Gene-modified cells vessels, tubing and connectors, samplers, and probes/sensor, among others)

By Type
• Stirred-tank SUBs
• Wave-induced SUBs
• Bubble-column SUBs
• Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)

By Type of Cell
• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Other Cells (Insect and plant cells)
 
By Molecule Type
• Monoclonal Antibodies
• Vaccines
• Gene-modified cells
• Stem Cells
• Other Molecules (Recombinant proteins including growth factors & interferons, antisense, and RNA interference)

By Application
• Research and Development (R&D)
• Process Development
• Bioproduction

By End User
• Pharmaceutical & Biopharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Single Use Bioreactors Market By Product,By Type,By Type of Cell,By Molecule Type,By Application,By  End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Typeology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Single Use Bioreactors Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Single Use Bioreactors Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Single Use Bioreactors Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Single Use Bioreactors Market,By Product Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Gene-modified cells Bioreactor Systems
       7.1.1. Up to 10L
       7.1.2. 11–100L
       7.1.3. 101–500L
       7.1.4. 501–1500L
       7.1.5. Other Cells (Insect and plant cells)
  7.2. Gene-modified cells Media Bags
       7.2.1. 2D Bags
       7.2.2. 3D Bags
       7.2.3. Other Bags
  7.3. Gene-modified cells Filtration Assemblies
  7.4. Other Products (Gene-modified cells vessels, tubing and connectors, samplers, and probes/sensor, among others)
 
8. Global Single Use Bioreactors Market,By Type Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Stirred-tank SUBs
  8.2. Wave-induced SUBs
  8.3. Bubble-column SUBs
  8.4. Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
       
9. Global Single Use Bioreactors Market,By Type of Cell Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Mammalian Cells
  9.2. Bacterial Cells
  9.3. Yeast Cells
  9.4. Other Cells (Insect and plant cells)
       
10. Global Single Use Bioreactors Market,By Molecule Type Historical Analysis and Forecast 2022-2028 (USD Million)  
   10.1. Monoclonal Antibodies
   10.2. Vaccines
   10.3. Gene-modified cells
   10.4. Stem Cells
   10.5. Other Molecules (Recombinant proteins including growth factors & interferons, antisense, and RNA interference)
   
11. Global Single Use Bioreactors Market,By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   11.1. Research and Development (R&D)
   11.2. Process Development
   11.3. Bioproduction
   
12. Global Single Use Bioreactors Market,By  End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   12.1. Pharmaceutical & Biopharmaceutical Companies
   12.2. CROs & CMOs
   12.3. Academic & Research Institutes

12. North America Single Use Bioreactors Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       12.2.1. U.S.A
       12.2.2. Canada
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2022-2028

13. Latin America Single Use Bioreactors Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2022-2028

14. Europe Single Use Bioreactors Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2022-2028

15. Asia Pacific Single Use Bioreactors Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

16. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         16.2.1. GCC
         16.2.2. Israel
         16.2.3. South Africa
         16.2.4. Rest of MEA
   16.3. Market Size (USD Million) Forecast for MEA 2022-2028

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4.  North America - Market Share Analysis and Key Regional Players
   17.5.  Europe - Market Share Analysis and Key Regional Players
   17.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   17.7.  Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   18.1. Sartorius Stedim Biotech
         18.1.1. Company Overview
         18.1.2. Product Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. Danaher Corporation
         18.2.1. Company Overview
         18.2.2. Product Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Thermo Fisher Scientific Inc.
         18.3.1. Company Overview
         18.3.2. Product Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Merck Millipore
         18.4.1. Company Overview
         18.4.2. Product Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. Eppendorf Ag
         18.5.1. Company Overview
         18.5.2. Product Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. Cesco Bioengineering Co., Ltd.
         18.6.1. Company Overview
         18.6.2. Product Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. Cellexus
         18.7.1. Company Overview
         18.7.2. Product Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. PBS Biotech, Inc.
         18.8.1. Company Overview
         18.8.2. Product Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Distek, Inc.
         18.9.1. Company Overview
         18.9.2. Product Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10.Abec, Inc.
         18.10.1. Company Overview
         18.10.2. Product Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11.Able Corporation & Biott Corporation
         18.11.1. Company Overview
         18.11.2. Product Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12.G&G Technologies, Inc.
         18.12.1. Company Overview
         18.12.2. Product Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13.Solida Biotech Gmbh
         18.13.1. Company Overview
         18.13.2. Product Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14.Satake Chemical Equipment Mfg., Ltd.
         18.14.1. Company Overview
         18.14.2. Product Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15.Stobbe Pharma Gmbh
         18.15.1. Company Overview
         18.15.2. Product Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview
   18.16.Celltainer Biotech BV
         18.16.1. Company Overview
         18.16.2. Product Portfolio
         18.16.3. SWOT Analysis
         18.16.4. Financial Overview
         18.16.5. Strategic Overview
   18.17.Meissner Filtration Products, Inc.
         18.17.1. Company Overview
         18.17.2. Product Portfolio
         18.17.3. SWOT Analysis
         18.17.4. Financial Overview
         18.17.5. Strategic Overview
   18.18.BBI-Biotech Gmbh
         18.18.1. Company Overview
         18.18.2. Product Portfolio
         18.18.3. SWOT Analysis
         18.18.4. Financial Overview
         18.18.5. Strategic Overview
   18.19.Pierre Guérin
         18.19.1. Company Overview
         18.19.2. Product Portfolio
         18.19.3. SWOT Analysis
         18.19.4. Financial Overview
         18.19.5. Strategic Overview
   
19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures